Position in EXEL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,644,759
+$423,510 QoQ
Shares Held
30,229
+6.2% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#285
of 755 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026QUADRANT CAPITAL GROUP LLC holds $22,827,015 across 21 Biotechnology names. EXEL ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,887 | $2,678,471 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,938 | $2,452,852 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,691 | $2,301,486 | |
| 4 | LGND |
Ligand Pharmaceuticals Inc
|
5,658 | $1,788,437 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
49,246 | $1,742,815 | |
| 6 | EXEL |
Exelixis, Inc.
This page
|
30,229 | $1,644,759 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
2,605 | $1,398,754 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
4,647 | $1,324,255 |
All Filings in EXEL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,644,759 | 30,229 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,221,249 | 28,474 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,229,562 | 28,053 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,140,706 | 27,620 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,221,368 | 27,708 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $697,529 | 18,893 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $208,158 | 6,251 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $155,985 | 6,011 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $130,550 | 5,810 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $158,563 | 6,682 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $184,938 | 7,709 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $152,054 | 6,959 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $129,240 | 6,763 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $127,620 | 6,575 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $43,259 | 2,697 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,439 | 1,176 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $17,551 | 843 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $28,133 | 1,241 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $13,161 | 720 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $18,180 | 860 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $17,181 | 943 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $34,088 | 1,509 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $27,214 | 1,356 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $38,679 | 1,582 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $36,203 | 1,525 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $17,975 | 1,044 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||